Printer Friendly

COPLEY PHARMACEUTICAL FILES REGISTRATION STATEMENT FOR SECOND PUBLIC OFFERING

 CANTON, Mass., March 31, 1993 /PRNewswire/ -- Copley Pharmaceutical, Inc. (NASDAQ: CPLY) announced today the filing of a registration statement with the Securities and Exchange Commission for a public offering of 1,825,000 shares of common stock, of which 500,000 will be sold by the company and 1,325,000 will be sold by certain stockholders of the company.
 The offering is expected to be completed prior to the company's previously announced three-for-two stock split of its common stock, declared as a dividend and payable on June 8, 1993 to stockholders of record at the close of business on May 18, 1993.
 Copley Pharmaceutical, Inc. develops, manufactures and markets a broad range of off-patent (generic) prescription and over-the-c pharmaceutical products in a variety of dosage forms and strengths, including extended release products.
 A registration statement relating to these securities has been filed with the securities and exchange commission but has not yet become effective. Information contained therein is subject to completion or amendment. The securities may not be sold, nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
 /NOTE: Bear, Stearns & Co. Inc. and Tucker Anthony Incorporated are managing underwriters for the offering, which will be made only by means of a Prospectus./
 -0- 3/31/93
 /CONTACT: Steven N. Tannenbaum, executive vice president-finance, 1-800-325-6111 or 617-821-6111, of Copley Pharmaceutical Inc./
 (CPLY)


CO: Copley Pharmaceutical Inc. ST: Massachusetts IN: MTC SU: OFR

SJ -- NE010 -- 1570 03/31/93 14:17 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 31, 1993
Words:306
Previous Article:HEALTHSOURCE ANNOUNCES CLOSING OF MERGER WITH SOUTH CAROLINA AFFILIATE
Next Article:AEROSPACE/DEFENSE INDUSTRY OFFERED STRATEGIC OPTIONS AND INFORMATION TO IMPLEMENT SOLUTIONS FOR CHANGE
Topics:


Related Articles
ISIS PHARMACEUTICALS FILES PUBLIC OFFERING FOR 2 MILLION SHARES OF COMMON STOCK
VERTEX PHARMACEUTICALS INTENDS TO FILE REGISTRATION STATEMENT WITH SEC TO SELL 2 MILLION SHARES OF COMMON STOCK
WATSON PHARMACEUTICALS ANNOUNCES FILING OF REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING
MAGAININ PHARMACEUTICALS INC. FILES FOR PROPOSED PUBLIC OFFERING
ISIS PHARMACEUTICALS FILES PUBLIC OFFERING FOR 2.5 MILLION SHARES OF COMMON STOCK
COPLEY PHARMACEUTICAL ANNOUNCES PUBLIC OFFERING OF COMMON STOCK
ROBERTS PHARMACEUTICAL CORPORATION FILES PROPOSED OFFERING OF COMMON STOCK WITH SEC
WATSON PHARMACEUTICALS ANNOUNCES FILING FOR PUBLIC OFFERING OF 2,000,000 SHARES OF COMMON STOCK
SPARTA PHARMACEUTICALS INC. ANNOUNCES PROPOSED INITIAL PUBLIC OFFERING
Sunesis Pharmaceuticals Announces Filing of Universal Shelf Registration Statement.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters